Vaccination using inactivated Mycoplasma pneumoniae induces detrimental infiltration of neutrophils after subsequent infection in mice

被引:13
作者
Tamiya, Shigeyuki [1 ,2 ,3 ]
Yoshikawa, Eisuke [1 ,2 ,3 ]
Ogura, Monami [1 ,2 ]
Kuroda, Etsushi [4 ,5 ]
Suzuki, Koichiro [6 ]
Yoshioka, Yasuo [1 ,2 ,3 ,6 ,7 ,8 ]
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Nanodesign Innovat Drug Dev, Suita, Osaka, Japan
[2] Osaka Univ, Res Inst Microbial Dis, BIKEN Innovat Vaccine Res Alliance Labs, Vaccine Creat Grp, Suita, Osaka, Japan
[3] Osaka Univ, Inst Open & Transdisciplinary Res Initiatives, BIKEN Innovat Vaccine Res Alliance Labs, Vaccine Creat Grp, Suita, Osaka, Japan
[4] Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo, Japan
[5] NIBIOHN, Lab Adjuvant Innovat, Ctr Vaccine & Adjuvant Res, Ibaraki, Osaka, Japan
[6] Osaka Univ, Res Fdn Microbial Dis, Suita, Osaka, Japan
[7] Osaka Univ, BIKEN Ctr Innovat Vaccine Res & Dev, Res Fdn Microbial Dis, Suita, Osaka, Japan
[8] Osaka Univ, Global Ctr Med Engn & Informat, Suita, Osaka, Japan
基金
日本学术振兴会;
关键词
Mycoplasma pneumoniae; Neutrophil; Pneumonia; Th17; Toll-like receptor 2; Vaccine; TLR2; RESPONSES; CHILDREN; IMMUNITY; TH17; SURVEILLANCE; RECRUITMENT; ACTIVATION; PROTECTION; EFFICACY;
D O I
10.1016/j.vaccine.2020.05.074
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mycoplasma pneumoniae (Mp) is one of the most common causes of community-acquired pneumonia. Given the emergence and high rates of antibiotic-resistant Mp strains, vaccines that prevent the pneumonia and secondary complications due to Mp infection are urgently needed. Although several studies have shown the protective efficacy of Mp vaccines in human clinical trials, some reports suggest that vaccination against Mp exacerbates disease upon subsequent Mp challenge. Therefore, to develop optimal vaccines against Mp, understanding the immune responses that contribute to post-vaccination exacerbation of inflammation is crucial. Here we examined whether Mp vaccination might exacerbate pneumonia after subsequent Mp infection in mice. We found that vaccination with inactivated Mp plus aluminum salts as an adjuvant induced Mp-specific IgG, Th1 cells, and Th17 cells. Toll-like receptor 2 signaling contributed to the induction of an Mp-specific IgG response and was necessary for Mp-specific Th17-cell-but not Th1-cell-responses in vaccinated mice. In addition, vaccination with inactivated Mp plus aluminum salts suppressed the number of Mp organisms in the bronchoalveolar lavage fluid, indicating that vaccination can reduce Mp infection. However, the numbers of total immune cells and neutrophils in bronchoalveolar lavage fluid after Mp challenge did not differ between vaccinated mice and non-vaccinated control mice. Furthermore, depletion of CD4(+) T cells prior to Mp challenge decreased pulmonary neutrophil infiltration in vaccinated mice, suggesting that Th1 or Th17 cells (or both) are responsible for the vaccination-induced neutrophil infiltration. These results suggest that, despite reducing Mp infection, vaccination of mice by using inactivated Mp fails to suppress inflammation, such as neutrophil infiltration into the lung, after subsequent Mp infection. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4979 / 4987
页数:9
相关论文
共 44 条
  • [1] Role of the Mycoplasma pneumoniae/Interleukin-8/Neutrophil Axis in the Pathogenesis of Pneumonia
    Chen, Zhengrong
    Shao, Xuejun
    Dou, Xunwu
    Zhang, Xinxing
    Wang, Yuqing
    Zhu, Canhong
    Hao, Chuangli
    Fan, Mingyue
    Ji, Wei
    Yan, Yongdong
    [J]. PLOS ONE, 2016, 11 (01):
  • [2] Repeated respiratory Mycoplasma pneumoniae infections in mice:: effect of host genetic background
    Chu, Hong Wei
    Breed, Rachel
    Rino, John G.
    Harbeck, Ronald J.
    Sills, Michael R.
    Martin, Richard J.
    [J]. MICROBES AND INFECTION, 2006, 8 (07) : 1764 - 1772
  • [3] TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression
    Chu, HW
    Jeyaseelan, S
    Rino, JG
    Voelker, DR
    Wexler, RB
    Campbell, K
    Harbeck, RJ
    Martin, RJ
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (09) : 5713 - 5719
  • [4] Mycoplasma pneumoniae reinfection and vaccination: Protective oral vaccination and harmful immunoreactivity after re-infection and parenteral immunization
    Cimolai, N
    Cheong, ACH
    Morrison, BJ
    Taylor, GP
    [J]. VACCINE, 1996, 14 (15) : 1479 - 1483
  • [5] BASES FOR THE EARLY IMMUNE-RESPONSE AFTER RECHALLENGE OR COMPONENT VACCINATION IN AN ANIMAL-MODEL OF ACUTE MYCOPLASMA-PNEUMONIAE PNEUMONITIS
    CIMOLAI, N
    MAH, DG
    TAYLOR, GP
    MORRISON, BJ
    [J]. VACCINE, 1995, 13 (03) : 305 - 309
  • [6] Toll-like receptor-2, but not toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection
    Darville, T
    O'Neill, JM
    Andrews, CW
    Nagarajan, UM
    Stahl, L
    Ojcius, DM
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (11) : 6187 - 6197
  • [7] A specific role for TLR1 in protective TH17 immunity during mucosal infection
    DePaolo, R. William
    Kamdar, Karishma
    Khakpour, Samira
    Sugiura, Yui
    Wang, Wenxia
    Jabri, Bana
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (08) : 1437 - 1444
  • [8] A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine
    Dunne, A.
    Mielke, L. A.
    Allen, A. C.
    Sutton, C. E.
    Higgs, R.
    Cunningham, C. C.
    Higgins, S. C.
    Mills, K. H. G.
    [J]. MUCOSAL IMMUNOLOGY, 2015, 8 (03) : 607 - 617
  • [9] FERNALD GW, 1975, PEDIATRICS, V55, P327
  • [10] Imbalance of peripheral blood Th17 and Treg responses in children with refractory Mycoplasma pneumoniae pneumonia
    Guo, Hongmei
    He, Zuhui
    Li, Mei
    Wang, Tingting
    Zhang, Langfan
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2016, 22 (03) : 162 - 166